These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34791656)

  • 1. Seizure outcome trajectories in a well-defined cohort of newly diagnosed juvenile myoclonic epilepsy patients.
    Cerulli Irelli E; Morano A; Orlando B; Salamone EM; Fanella M; Fattouch J; Manfredi M; Giallonardo AT; Di Bonaventura C
    Acta Neurol Scand; 2022 Mar; 145(3):314-321. PubMed ID: 34791656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020.
    Kılıç B; Serdaroğlu E; Polat BG; İnce T; Esenülkü G; Topçu Y; Serdaroğlu A; Haspolat Ş; Tekgül H; Okuyaz Ç; Cansu A; Aydın K
    Seizure; 2022 Jul; 99():48-53. PubMed ID: 35594744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile myoclonic epilepsy: Long-term prognosis and risk factors.
    Pietrafusa N; La Neve A; de Palma L; Boero G; Luisi C; Vigevano F; Specchio N
    Brain Dev; 2021 Jun; 43(6):688-697. PubMed ID: 33781581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epilepsy with generalized tonic-clonic seizures alone: Electroclinical features and prognostic patterns.
    Cerulli Irelli E; Gesche J; Schlabitz S; Fortunato F; Catania C; Morano A; Labate A; Vorderwülbecke BJ; Gambardella A; Baykan B; Holtkamp M; Di Bonaventura C; Beier CP
    Epilepsia; 2024 Jan; 65(1):84-94. PubMed ID: 37872695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy.
    Johannessen Landmark C; Fløgstad I; Syvertsen M; Baftiu A; Enger U; Koht J; Johannessen SI
    Epilepsy Behav; 2019 Sep; 98(Pt A):110-116. PubMed ID: 31330379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China.
    Wang L; Jiang Z; Chen BB; Wang CT; Wang JX; Bai J; Wang B; Jin L; Zhang WJ; Deng YC; Zhao G; Dang JX; Wang D; Jia SS; Wang TC; Jia FY; Zhang L; Liu YH
    Epilepsy Behav; 2016 Sep; 62():204-8. PubMed ID: 27494356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical heterogeneity of juvenile myoclonic epilepsy: follow-up after an interval of more than 20 years.
    Syvertsen MR; Thuve S; Stordrange BS; Brodtkorb E
    Seizure; 2014 May; 23(5):344-8. PubMed ID: 24512779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy.
    Gürer R; Aydın Ş; Özkara Ç
    Seizure; 2019 Aug; 70():43-48. PubMed ID: 31252363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors.
    Senf P; Schmitz B; Holtkamp M; Janz D
    Neurology; 2013 Dec; 81(24):2128-33. PubMed ID: 24212391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizure outcome in 175 patients with juvenile myoclonic epilepsy--a long-term observational study.
    Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E
    Epilepsy Res; 2014 Dec; 108(10):1817-24. PubMed ID: 25443450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of seizure control in patients with juvenile myoclonic epilepsy (JME).
    Asadi-Pooya AA; Hashemzehi Z; Emami M
    Seizure; 2014 Nov; 23(10):889-91. PubMed ID: 25189101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent treatment resistance in genetic generalized epilepsy: A long-term outcome study in a tertiary epilepsy center.
    Cerulli Irelli E; Morano A; Barone FA; Fisco G; Fanella M; Orlando B; Fattouch J; Manfredi M; Giallonardo AT; Di Bonaventura C
    Epilepsia; 2020 Nov; 61(11):2452-2460. PubMed ID: 33345323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up.
    Geithner J; Schneider F; Wang Z; Berneiser J; Herzer R; Kessler C; Runge U
    Epilepsia; 2012 Aug; 53(8):1379-86. PubMed ID: 22686598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of epilepsy with generalized tonic-clonic seizures alone: Clinical features, response to treatment, and likelihood of medication withdrawal.
    Jaafar F; Wazne J; Hmaimess G; Nasreddine W; Beydoun A; Shatila A; Beydoun A
    Epilepsia Open; 2024 Aug; 9(4):1426-1436. PubMed ID: 38819591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse after treatment withdrawal of antiepileptic drugs for Juvenile Absence Epilepsy and Juvenile Myoclonic Epilepsy.
    Healy L; Moran M; Singhal S; O'Donoghue MF; Alzoubidi R; Whitehouse WP
    Seizure; 2018 Jul; 59():116-122. PubMed ID: 29807291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence rates and risk factors for seizure recurrence following antiseizure medication withdrawal in adolescent patients with genetic generalized epilepsy.
    Komatsubara T; Kobayashi Y; Hiraiwa A; Magara S; Hojo M; Ono T; Okazaki K; Fukuda M; Tohyama J
    Epilepsia Open; 2022 Jun; 7(2):332-343. PubMed ID: 35445562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year efficacy of lacosamide as adjunctive therapy for generalized tonic-clonic seizures in patients with juvenile myoclonic epilepsy.
    Kobayashi Y; Honda R; Yamada K; Hojo M; Miura M; Seki E; Ono T; Tohyama J
    Brain Dev; 2023 Sep; 45(8):451-455. PubMed ID: 37308336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy.
    Ascoli M; Mastroianni G; Gasparini S; Striano P; Cianci V; Neri S; Bova V; Mammì A; Gambardella A; Labate A; Aguglia U; Ferlazzo E
    Expert Rev Neurother; 2021 Nov; 21(11):1265-1273. PubMed ID: 33993822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high.
    Hernández-Vanegas LE; Jara-Prado A; Ochoa A; Rodríguez Y Rodríguez N; Durón RM; Crail-Meléndez D; Alonso ME; Delgado-Escueta AV; Martínez-Juárez IE
    Epilepsy Behav; 2016 Aug; 61():34-40. PubMed ID: 27300146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.